Abstract
This study assessed whether the Symax implant, a modification of the Omnifit((R)) stem (in terms of shape, proximal coating and distal surface treatment), would yield improved bone remodelling in a clinical DEXA study, and if these results could be predicted in a finite element (FE) simulation study. In a randomized clinical trial, 2 year DEXA measurements between the uncemented Symax and Omnifit((R)) stem (both n=25) showed bone mineral density (BMD) loss in Gruen zone 7 of 14% and 20%, respectively (p<0.05). In contrast, the FE models predicted a 28% (Symax) and 26% (Omnifit((R))) bone loss. When the distal treatment to the Symax was not modelled in the simulation, bone loss of 35% was predicted, suggesting the benefit of this surface treatment for proximal bone maintenance. The theoretical concept for enhanced proximal bone loading by the Symax, and the predicted remodelling pattern were confirmed by DEXA-results, but there was no quantitative match between clinical and FE findings. This was due to a simulation based on incomplete assumptions concerning the yet unknown biological and mechanical effects of the new coating and surface treatment. Study listed under ClinicalTrials.gov with number NCT01695213.
Original language | English |
---|---|
Pages (from-to) | 345-353 |
Number of pages | 9 |
Journal | Medical Engineering & Physics |
Volume | 36 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 2014 |
Keywords
- Cementless hip arthroplasty
- Bone mineral density
- Finite element analysis
- DEXA
- COATED FEMORAL STEMS
- PROXIMAL FIXATION
- CANCELLOUS BONE
- MINERAL DENSITY
- HYDROXYAPATITE
- ARTHROPLASTY
- INTERFACE
- REPLACEMENT
- COMPONENTS
- RESORPTION